Amander, Arissa Yara S.

HRN: 25-80-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2026
CEFTRIAXONE 1G (VIAL)
04/20/2026
04/27/2026
IV
1.2g
OD
T/C Typhoid Fever; T/C UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: